Assay Detail
Binding
CHEMBL5503164
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of VEGFR2 (unknown origin)
21
Total Activities
21
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Target
Vascular endothelial growth factor receptor 2 (CHEMBL279) ↗| Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
Publication
Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 21 | 6.77 | 8.32 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5549937 | — | — | 1 | 8.32 |
| CHEMBL5418423 | — | — | 1 | 8.15 |
| CHEMBL5517643 | — | — | 1 | 7.80 |
| CHEMBL5556008 | — | — | 1 | 7.60 |
| CHEMBL5542272 | — | — | 1 | 7.50 |
| CHEMBL5518141 | — | — | 1 | 7.31 |
| CHEMBL1336 | SORAFENIB | 4.0 | 1 | 7.24 |
| CHEMBL5505791 | — | — | 1 | 7.17 |
| CHEMBL5559400 | — | — | 1 | 7.16 |
| CHEMBL24828 | VANDETANIB | 4.0 | 1 | 7.03 |
| CHEMBL5512476 | — | — | 1 | 7.01 |
| CHEMBL5557132 | — | — | 1 | 6.96 |
| CHEMBL5558244 | — | — | 1 | 6.64 |
| CHEMBL5427272 | — | — | 1 | 5.96 |
| CHEMBL5532112 | — | — | 1 | 5.91 |
| CHEMBL5437292 | — | — | 1 | 5.44 |
| CHEMBL5517680 | — | — | 1 | 5.23 |
| CHEMBL5403883 | — | — | 1 | 5.09 |
| CHEMBL5557202 | — | — | 1 | 5.03 |
| CHEMBL5557998 | — | — | 1 | - |
| CHEMBL5558572 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5549937 | — | IC50 | = | 4.8 | nM | 8.32 |
| CHEMBL5418423 | — | IC50 | = | 7.0 | nM | 8.15 |
| CHEMBL5517643 | — | IC50 | = | 16.0 | nM | 7.80 |
| CHEMBL5556008 | — | IC50 | = | 25.0 | nM | 7.60 |
| CHEMBL5542272 | — | IC50 | = | 32.0 | nM | 7.50 |
| CHEMBL5518141 | — | IC50 | = | 49.0 | nM | 7.31 |
| CHEMBL1336 | SORAFENIB | IC50 | = | 58.0 | nM | 7.24 |
| CHEMBL5505791 | — | IC50 | = | 67.0 | nM | 7.17 |
| CHEMBL5559400 | — | IC50 | = | 70.0 | nM | 7.16 |
| CHEMBL24828 | VANDETANIB | IC50 | = | 94.0 | nM | 7.03 |
| CHEMBL5512476 | — | IC50 | = | 98.0 | nM | 7.01 |
| CHEMBL5557132 | — | IC50 | = | 111.0 | nM | 6.96 |
| CHEMBL5558244 | — | IC50 | = | 230.11 | nM | 6.64 |
| CHEMBL5427272 | — | IC50 | = | 1090.0 | nM | 5.96 |
| CHEMBL5532112 | — | IC50 | = | 1230.0 | nM | 5.91 |
| CHEMBL5437292 | — | IC50 | = | 3620.0 | nM | 5.44 |
| CHEMBL5517680 | — | IC50 | = | 5873.0 | nM | 5.23 |
| CHEMBL5403883 | — | IC50 | = | 8200.0 | nM | 5.09 |
| CHEMBL5557202 | — | IC50 | = | 9400.0 | nM | 5.03 |
| CHEMBL5557998 | — | IC50 | = | 19780.0 | nM | - |
| CHEMBL5558572 | — | IC50 | = | 25140.0 | nM | - |